A 2020 View of Tickborne Diseases

Watch the webinar series on demand

A two-part, on-demand webinar series featuring tickborne diseases and testing

Ticks are currently considered to be second only to mosquitoes as vectors of human infectious diseases in the world. Each tick species has preferred environmental conditions and habitat that determine the geographic distribution of the ticks and, consequently, the risk areas for tick-borne diseases. Tick-borne diseases are becoming more frequently diagnosed as the cause of human infections as animal reservoirs and tick vectors have increased in numbers and humans have inhabited areas where reservoir and tick populations are high.

Ticks may become infected and harbor one or more disease-causing agents (e.g. bacteria, viruses, or parasites) and co-infection can also occur, compounding the difficulty in diagnosis and treatment. Co-infections often prove to cause worse symptoms than a single infection alone. In most cases, patients present severe atypical clinical manifestations, wider range of secondary symptoms, and longer recovery. Co-infections can be challenging to diagnose, as clinical features of tickborne diseases often overlap. Identifying and treating polymicrobial infections are critical as morbidity and mortality increases substantially if there are delays in diagnosis and treatment.

Objectives of the webinar series include:

  • Ensure participants understand the mew MTTT testing paradigm.
  • Appreciate the prevalence of co-infections with more than one pathogen.
  • Provide information on test ordering and interpretations for tick-borne diseases.

Featured Speakers

TickBorne Testing Solutions™ – Overview 2020
Philip J Molloy, MD
Medical Director for Tick-Borne Diseases
East Side Clinical Laboratory

Identifying the Tickborne Pathogens that Summer in Vacationland
Sarah Buss, PhD, D(ABMM)
Director, Clinical Microbiology
Northern Light Health, Bangor, ME

Watch the webinar series on demand